# Transdermal Cap, Inc.

- Location (FDA's records): Cleveland, OH
- FDA decisions: 3 (2015–2021): 3 510(k) clearances
- Product codes: OAP (3)
- Predicates its devices cite: 9 (3 its own); citations of its devices by later devices: 11 (3 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Capillus, LLC: 5 (https://510kreport.com/company/capillus)
- Theradome, Inc.: 1 (https://510kreport.com/company/theradome)

## Firms that cite its devices most
- Dermascalp, LLC: 2 (https://510kreport.com/company/dermascalp)
- Capillus, LLC: 2 (https://510kreport.com/company/capillus)
- Advihair S.R.L.: 1 (https://510kreport.com/company/advihair)
- Lexington International, LLC: 1 (https://510kreport.com/company/lexington-international)
- Hubei Yjt Technology Co.,Ltd: 1 (https://510kreport.com/company/hubei-yjt-technology)
- Eglobal, LLC: 1 (https://510kreport.com/company/eglobal)

## Its most-cited devices
- K161875: LaserCap300, LaserCap224, LaserCap120, LaserCap80 (2016), cited by 6
- K150613: LaserCap LC Pro and LC Elite (2015), cited by 4
- K203826: LaserCap Family of Lasers 300, 224, 120 & 80 (2021), cited by 1

## Recent decisions
- K203826: LaserCap Family of Lasers 300, 224, 120 & 80 (Mar 29, 2021)
- K161875: LaserCap300, LaserCap224, LaserCap120, LaserCap80 (Sep 30, 2016)
- K150613: LaserCap LC Pro and LC Elite (Jul 22, 2015)

Source page: https://510kreport.com/company/transdermal-cap